Cresset Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
VCM
VPM
Cresset Asset Management's VRTX Position: Q1 2026 in Review
Cresset Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 4% in Q1 2026, buying an estimated $142K and bringing the position to 7,860 shares worth $3.51M. The position accounts for 0.02% of the portfolio, ranked #442.
Cresset Asset Management first reported a position in VRTX in Q4 2018 and has held it in 28 quarters since. The position peaked at $11.2M in Q3 2024. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Cresset Asset Management held 7,860 shares of Vertex Pharmaceuticals worth $3.51M as of Q1 2026.
- Cresset Asset Management bought 305 Vertex Pharmaceuticals shares in Q1 2026, an estimated $142K.
- Vertex Pharmaceuticals made up 0.02% of Cresset Asset Management's portfolio in Q1 2026, its #442 holding.
- Cresset Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 28 quarters since.
- Cresset Asset Management's Vertex Pharmaceuticals position peaked at $11.2M in Q3 2024.
- 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.